Literature DB >> 10075648

The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300.

M C Faniello1, M A Bevilacqua, G Condorelli, B de Crombrugghe, S N Maity, V E Avvedimento, F Cimino, F Costanzo.   

Abstract

We report that the heterotrimeric transcription factor NFY or "CAAT-binding factor" binds the -60 region of the human H ferritin promoter, the B site. DNA binding analysis with specific antibodies demonstrates that NFY/B/C subunits tightly bind this site and that NFY/C subunit is masked in vivo by binding with other protein(s). NFY binds the co-activator p300. Specifically, the NFY/B subunit interacts with the central segment of p300 in vivo and in vitro. cAMP substantially increases the formation of the NFY.p300 complex. Taken together these data provide a general model of cAMP induction of non-CRE-containing promoters and suggest that the NFY-B.p300 complex is located at the 5' end of the promoter and the NFY-B.C. TFIIB on the 3' end toward the transcription start site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075648     DOI: 10.1074/jbc.274.12.7623

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  An alternative model of H ferritin promoter transactivation by c-Jun.

Authors:  Maria C Faniello; Giuseppa Chirico; Barbara Quaresima; Giovanni Cuda; Giovanna Allevato; Maria A Bevilacqua; Francesco Baudi; Vittorio Colantuoni; Filiberto Cimino; Salvatore Venuta; Vittorio E Avvedimento; Francesco Costanzo
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

2.  Characterization of the human ephrin-A4 promoter.

Authors:  Else Munthe; Hans-Christian Aasheim
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

3.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

4.  The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.

Authors:  Rosalind M Glasspool; Sharon Burns; Stacey F Hoare; Catharina Svensson; W Nicol Keith
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

5.  Variation in transcription factor binding among humans.

Authors:  Maya Kasowski; Fabian Grubert; Christopher Heffelfinger; Manoj Hariharan; Akwasi Asabere; Sebastian M Waszak; Lukas Habegger; Joel Rozowsky; Minyi Shi; Alexander E Urban; Mi-Young Hong; Konrad J Karczewski; Wolfgang Huber; Sherman M Weissman; Mark B Gerstein; Jan O Korbel; Michael Snyder
Journal:  Science       Date:  2010-03-18       Impact factor: 47.728

6.  Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.

Authors:  Francesca De Amicis; Francesca Giordano; Adele Vivacqua; Michele Pellegrino; Maria Luisa Panno; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  FASEB J       Date:  2011-07-07       Impact factor: 5.191

7.  Nuclear factor Y and steroidogenic factor 1 physically and functionally interact to contribute to cell-specific expression of the mouse Follicle-stimulating hormone-beta gene.

Authors:  Suzanne B R Jacobs; Djurdjica Coss; Shauna M McGillivray; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2003-05-01

8.  An evolutionarily conserved Myostatin proximal promoter/enhancer confers basal levels of transcription and spatial specificity in vivo.

Authors:  Carla Vermeulen Carvalho Grade; Mônica Senna Salerno; Frank R Schubert; Susanne Dietrich; Lúcia Elvira Alvares
Journal:  Dev Genes Evol       Date:  2010-01-06       Impact factor: 0.900

9.  Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells.

Authors:  Kenta Iwasaki; Elizabeth L Mackenzie; Kiros Hailemariam; Kensuke Sakamoto; Yoshiaki Tsuji
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells.

Authors:  P Tassone; P Tagliaferri; A Perricelli; S Blotta; B Quaresima; M L Martelli; A Goel; V Barbieri; F Costanzo; C R Boland; S Venuta
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.